Sandra O'neill
Dundee, SCT DD15EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contamination.
Journal: SLAS technology
Published: November 28, 2025
Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferase.
Journal: RSC medicinal chemistry
Published: October 08, 2025
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening.
Journal: SLAS discovery : advancing life sciences R & D
Published: May 30, 2025
Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity.
Journal: PLoS neglected tropical diseases
Published: July 27, 2023
Development of a High-Throughput Screening Assay to Identify Inhibitors of the Major M17-Leucyl Aminopeptidase from Trypanosoma cruzi Using RapidFire Mass Spectrometry.
Journal: SLAS discovery : advancing life sciences R & D
Published: May 14, 2020
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site.
Journal: Nature communications
Published: January 09, 2020
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 22, 2019
A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes.
Journal: PLoS neglected tropical diseases
Published: May 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026